The GPCR pathways in our study included genes such as S100B, Nos1, Ccl5/RANTES, and Ccl3/MIP1a (Figure 6b–e), which have previously been associated with neuroinflammation in AD [45,46,47] and epileptic activity [48]. This evidence concerns the gene S100B and Alzheimer disease.